GALIMBERTI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 350
EU - Europa 150
AS - Asia 106
OC - Oceania 1
Totale 607
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 347
IT - Italia 49
SG - Singapore 39
CN - Cina 31
SE - Svezia 29
DE - Germania 27
HK - Hong Kong 24
GB - Regno Unito 14
ID - Indonesia 6
FI - Finlandia 5
LT - Lituania 5
FR - Francia 4
NL - Olanda 4
BG - Bulgaria 3
IE - Irlanda 3
CA - Canada 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
JO - Giordania 2
JP - Giappone 2
RU - Federazione Russa 2
AU - Australia 1
BZ - Belize 1
CH - Svizzera 1
IN - India 1
IR - Iran 1
Totale 607
Salva come PNG Salva come JPEG
Città #
Santa Clara 58
Fairfield 48
Chandler 44
Singapore 31
Ashburn 30
Nyköping 28
Hong Kong 22
Cambridge 16
New York 14
Woodbridge 14
Seattle 13
Frankfurt am Main 12
Houston 12
Princeton 7
Wilmington 7
Beijing 6
Jakarta 6
Southend 6
Helsinki 5
Modena 5
Saint Louis 5
Bremen 4
Novate Milanese 4
San Diego 4
Amsterdam 3
Dublin 3
Lavello 3
London 3
Philadelphia 3
Sofia 3
Amman 2
Ann Arbor 2
Brno 2
Carpi 2
Castelnuovo Rangone 2
Cinisello Balsamo 2
Conegliano 2
Genoa 2
Kilburn 2
Milan 2
Munich 2
Ottawa 2
Redwood City 2
Romainville 2
Rome 2
Tokyo 2
Belize City 1
Bengaluru 1
Bethesda 1
Carpaneto Piacentino 1
Chicago 1
Chiswick 1
Dongguan 1
Duncan 1
Garbagnate Milanese 1
Giugliano in Campania 1
Hillsboro 1
Hounslow 1
Jacksonville 1
Monza 1
Moscow 1
Norwalk 1
San Giuliano Milanese 1
Shanghai 1
Southwark 1
Totale 470
Salva come PNG Salva come JPEG
Nome #
Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: A randomized clinical trial 155
Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting 96
Long-term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high-dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma 91
Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study 64
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies 59
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV 37
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study 37
Impact of immunochemotherapy with R-bendamustine or R-CHOP for treatment naïve advanced-stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi 32
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome 23
Clinicopathological, cytogenetic, and molecular profiles of primary cutaneous diffuse large B-cell lymphomas 16
End of induction [18F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial 11
Totale 621
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.005
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.005
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021124 0 5 1 7 24 2 12 12 12 26 11 12
2021/202269 6 0 0 1 0 8 0 5 6 6 19 18
2022/2023149 14 18 10 14 18 15 11 17 14 4 6 8
2023/2024141 4 10 8 13 30 15 13 10 2 3 12 21
2024/2025138 24 2 11 41 60 0 0 0 0 0 0 0
Totale 621